BioNTech CEO Ugur Sahin Talks About 'Manufacturing Challenge' Of Producing Enough COVID-19 Vaccines

Now that the vaccine from Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) has been given the greenlight from the U.S. Food and Drug Administration, the companies have to scale up rapidly to meet demand.

Why It Matters: BioNTech CEO Ugur Sahin in an interview with Reuters talked about the ramp-up production.